Results 221 to 230 of about 508,660 (358)

Potential of mesenchymal stem cell-derived exosomes in the treatment of androgenetic alopecia. [PDF]

World J Stem Cells
Rajendran RL, Ahn BC, Gangadaran P.
europepmc   +1 more source

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

, 2003
Ida Rasmusson, Olle Ringdén, Berit Sundberg, Katarina Le Blanc   +3 more
openalex   +1 more source

RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy

Advanced Healthcare Materials, EarlyView.
An RBC membrane camouflaged, cell‐penetrating peptides R8‐based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), inducing tumor cell apoptosis, reducing tumor metastasis invasion and triggering autophagy disorder in breast cancer and liver cancer.
Qian Cheng, Xuemei Zhong, Lu Deng, Xinling He, Miaoxizi Luo, Ruibing Wang, Jinming Zhang   +6 more
wiley   +1 more source

The Characterization of Serum-Free Media on Human Mesenchymal Stem Cell Fibrochondrogenesis. [PDF]

Bioengineering (Basel)
Kwan KYC, Li K, Wang YY, Tse WY, Tong CY, Zhang X, Wang DM, Ker DFE.   +7 more
europepmc   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles Reverse Endothelial-Mesenchymal Transition in Atherosclerosis. [PDF]

J Extracell Vesicles
Chen Z, Chang K, Yang S, Deng R, He Y, Zhang L, Chen M, Bai D, Pi Y.   +8 more
europepmc   +1 more source

Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells [PDF]

, 2004
Qing Luo, Quan Kang, Weike Si, Wei Jiang, Jong Kyung Park, Ying Peng, Xinmin Li, Hue H. Luu, Jeffrey Luo, Anthony Montag, Rex C. Haydon, Tong‐Chuan He   +11 more
openalex   +1 more source

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

Advanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang, Mengyuan Qian, Yirui Shi, Jiaxu Cao, Min Xu, Xin Wen, Yunxia Yan, Sha Liu, Hongwei Chen, Shanshan Liu, Jun Yang, Lingyun Sun   +11 more
wiley   +1 more source

Progress of bone marrow mesenchymal stem cell transplantation on neural plasticity in brain. [PDF]

Front Cell Dev Biol
Li W, Liu X, Li J.
europepmc   +1 more source

Human mesenchymal stem cells modulate allogeneic immune cell responses [PDF]

, 2004
Sudeepta Aggarwal, Mark F. Pittenger
openalex   +1 more source